Breaking News: DEA Issues New Guidance for Pharmacy Delivery of Patient-Specific Controlled Substances to Practitioners as An Alternative to the Limitations of 21 USC 829a
DEA Telemedicine Special Registration Rule Moves to OIRA: What It Means and Why Stakeholders Should Consider an EO 12866 Meeting
DEAs New EMS Regulations Took Effect in 2026, Are You Compliant? Learn More from the Excellent Training Provided by PWW Advisory Group.
Brinks DEA Consulting Welcomes Daniel Dormont, One of the Nation’s Leading Controlled Substances Experts
Breaking News: DEA Issues Technical Amendments to DEA Form 222 Regulations: What Registrants Need to Know
